Clinical Trial Detail

NCT ID NCT02566772
Title Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors Taiho Oncology, Inc.
Indications

prostate cancer

Therapies

TAS3681

Age Groups: adult

No variant requirements are available.